Literature DB >> 9130251

Immortalized schwann cells express endothelin receptors coupled to adenylyl cyclase and phospholipase C.

P L Wilkins1, D Suchovsky, L N Berti-Mattera.   

Abstract

Endothelins (ETs) are potent regulators of renal, cardiovascular and endocrine functions and act as neurotransmitters in the CNS. Here we report that immortalized Schwann cells express receptors for ETs and characterize some of the cellular events triggered by their activation. Specific binding of [125I]-ET-1 to Schwann cell membranes was inhibited by ET-1 and ETB-selective agonists ET-3, sarafotoxin 6c and [Ala1,3,11,15]-ET-1 with IC50cor values ranging between 2 and 20 nM. No competition was observed with the ETA receptor-selective antagonist BQ123. Incubation of [3H]-inositol pre-labeled Schwann cells with ET-1, ET-3 or sarafotoxin 6c elicited a concentration-dependent increase in the release of [P1 that reached a plateau at approximately 100 nM. The efficacy of [Ala1,3,11,15]-ET-1 (a linear peptide analog of ET-1) was half of that corresponding to ET-1. These stimulatory effects were partially blocked by pre-incubation with pertussis toxin. When Schwann cells were incubated in the presence of 100 nM ET-1 or ET-3 there was a significant inhibition of basal and isoproterenol-stimulated cAMP levels. The inhibitory effects of sarafotoxin 6c and [Ala1,3,11,15]-ET-1 on isoproterenol-stimulated cAMP levels were similar to that observed with ET-1. Pre-incubation with pertussis toxin completely prevented this effect. These observations indicate that immortalized Schwann cells express receptors for ET peptides (predominantly ETB) coupled to modulation of phospholipase C and adenylyl cyclase activities. The actions of ETs on Schwann cells provide a novel example of the influence of vascular factors on nerve function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130251     DOI: 10.1023/a:1027351525446

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  63 in total

1.  A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes.

Authors:  H Ehrenreich; J H Kehrl; R W Anderson; P Rieckmann; L Vitkovic; J E Coligan; A S Fauci
Journal:  Brain Res       Date:  1991-01-04       Impact factor: 3.252

2.  Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries.

Authors:  R F Power; J Wharton; S P Salas; S Kanse; M Ghatei; S R Bloom; J M Polak
Journal:  Eur J Pharmacol       Date:  1989-01-24       Impact factor: 4.432

3.  A cyclic AMP analogue induces synthesis of a myelin-specific glycoprotein by cultured Schwann cells.

Authors:  S Shuman; M Hardy; G Sobue; D Pleasure
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

4.  Release of autocrine growth factor by primary and immortalized Schwann cells.

Authors:  S Porter; L Glaser; R P Bunge
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  BQ-123 inhibits both endothelin 1 and endothelin 3 mediated C6 rat glioma cell proliferation suggesting an atypical endothelin receptor.

Authors:  P Provero; R P Revoltella; V Di Bartolo; P Beffy; J Mizrahi
Journal:  J Biol Regul Homeost Agents       Date:  1993 Jul-Sep       Impact factor: 1.711

6.  Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia.

Authors:  A Giaid; S J Gibson; B N Ibrahim; S Legon; S R Bloom; M Yanagisawa; T Masaki; I M Varndell; J M Polak
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

7.  Expression of the myelin-associated glycoprotein in cultures of immortalized Schwann cells.

Authors:  S Goda; J Hammer; D Kobiler; R H Quarles
Journal:  J Neurochem       Date:  1991-04       Impact factor: 5.372

8.  Astrocyte growth is regulated by neuropeptides through Tis 8 and basic fibroblast growth factor.

Authors:  R M Hu; E R Levin
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

9.  ETB receptor involvement in stimulatory and neurotoxic action of endothelin on dopamine neurones.

Authors:  M Kohzuma; Y Kataoka; S Koizumi; H Shibaguchi; M N Nakashima; K Yamashita; M Niwa; K Taniyama
Journal:  Neuroreport       Date:  1994-12-20       Impact factor: 1.837

10.  Axons regulate Schwann cell expression of the major myelin and NGF receptor genes.

Authors:  G Lemke; M Chao
Journal:  Development       Date:  1988-03       Impact factor: 6.868

View more
  5 in total

1.  Dietary sodium modulates the interaction between efferent renal sympathetic nerve activity and afferent renal nerve activity: role of endothelin.

Authors:  Ulla C Kopp; Olaf Grisk; Michael Z Cicha; Lori A Smith; Antje Steinbach; Torsten Schlüter; Nicole Mähler; Tomas Hökfelt
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-05-27       Impact factor: 3.619

2.  Phospholipase C-delta1 and oxytocin receptor signalling: evidence of its role as an effector.

Authors:  E S Park; J H Won; K J Han; P G Suh; S H Ryu; H S Lee; H Y Yun; N S Kwon; K J Baek
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

3.  Hyperglycemia triggers abnormal signaling and proliferative responses in Schwann cells.

Authors:  Khaldoun Almhanna; Pamela L Wilkins; James R Bavis; Subash Harwalkar; Liliana N Berti-Mattera
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

4.  Investigation of the Hydrogen Sulfide Signaling Pathway in Schwann Cells during Peripheral Nerve Degeneration: Multi-Omics Approaches.

Authors:  Yoo Lim Chun; Won-Joon Eom; Jun Hyung Lee; Thy N C Nguyen; Ki-Hoon Park; Hyung-Joo Chung; Han Seo; Youngbuhm Huh; Sang Hoon Kim; Seung Geun Yeo; Wonseok Park; Geul Bang; Jin Young Kim; Min-Sik Kim; Na Young Jeong; Junyang Jung
Journal:  Antioxidants (Basel)       Date:  2022-08-19

5.  Transcriptional regulation induced by cAMP elevation in mouse Schwann cells.

Authors:  Daniela Schmid; Thomas Zeis; Nicole Schaeren-Wiemers
Journal:  ASN Neuro       Date:  2014-04-30       Impact factor: 4.146

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.